Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Fruman

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
Oncotarget|February 22, 2018
mTOR inhibition enhances efficacy of dasatinib in <i>ABL</i>-rearranged Ph-like B-ALLMoran Gotesman, Thanh-Trang T Vo, Lee-Or Herzog, et al.
Blood|September 7, 2006
KLF4 suppresses transformation of pre-B cells by ABL oncogenesMichael G Kharas, Isharat Yusuf, Vanessa M Scarfone, et al.
Molecular and Cellular Biology|March 16, 2005
Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangementSaskia M Brachmann, Claudine M Yballe, Metello Innocenti, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2006
Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinaseJean S Oak, Jonathan A Deane, Michael G Kharas, et al.
The Journal of Clinical Investigation|August 16, 2008
Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cellsMichael G Kharas, Matthew R Janes, Vanessa M Scarfone, et al.
Biomaterials|September 19, 2013
A polyvalent aptamer system for targeted drug deliveryZhiqing Zhang, M Monsur Ali, Mark A Eckert, et al.
Stem Cells Translational Medicine|March 16, 2018
The CD11a and Endothelial Protein C Receptor Marker Combination Simplifies and Improves the Purification of Mouse Hematopoietic Stem CellsAlborz Karimzadeh, Vanessa M Scarfone, Erika Varady, et al.
Molecular Cancer Therapeutics|May 4, 2018
Targeting the Mevalonate Pathway Suppresses VHL-Deficient CC-RCC through an HIF-Dependent MechanismJordan M Thompson, Alejandro Alvarez, Monika K Singha, et al.
ACS Nano|July 30, 2016
Viral/Nonviral Chimeric Nanoparticles To Synergistically Suppress Leukemia Proliferation via Simultaneous Gene Transduction and SilencingCheol Am Hong, Soo Kyung Cho, Julius A Edson, et al.
Oncotarget|January 11, 2015
mTOR kinase inhibitors synergize with histone deacetylase inhibitors to kill B-cell acute lymphoblastic leukemia cellsBrandon R Beagle, Duc M Nguyen, Sharmila Mallya, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Oncotarget|February 22, 2018
mTOR inhibition enhances efficacy of dasatinib in <i>ABL</i>-rearranged Ph-like B-ALLMoran Gotesman, Thanh-Trang T Vo, Lee-Or Herzog, et al.
Blood|September 7, 2006
KLF4 suppresses transformation of pre-B cells by ABL oncogenesMichael G Kharas, Isharat Yusuf, Vanessa M Scarfone, et al.
Molecular and Cellular Biology|March 16, 2005
Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangementSaskia M Brachmann, Claudine M Yballe, Metello Innocenti, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 31, 2006
Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinaseJean S Oak, Jonathan A Deane, Michael G Kharas, et al.
The Journal of Clinical Investigation|August 16, 2008
Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cellsMichael G Kharas, Matthew R Janes, Vanessa M Scarfone, et al.
Biomaterials|September 19, 2013
A polyvalent aptamer system for targeted drug deliveryZhiqing Zhang, M Monsur Ali, Mark A Eckert, et al.
Stem Cells Translational Medicine|March 16, 2018
The CD11a and Endothelial Protein C Receptor Marker Combination Simplifies and Improves the Purification of Mouse Hematopoietic Stem CellsAlborz Karimzadeh, Vanessa M Scarfone, Erika Varady, et al.
Molecular Cancer Therapeutics|May 4, 2018
Targeting the Mevalonate Pathway Suppresses VHL-Deficient CC-RCC through an HIF-Dependent MechanismJordan M Thompson, Alejandro Alvarez, Monika K Singha, et al.
ACS Nano|July 30, 2016
Viral/Nonviral Chimeric Nanoparticles To Synergistically Suppress Leukemia Proliferation via Simultaneous Gene Transduction and SilencingCheol Am Hong, Soo Kyung Cho, Julius A Edson, et al.
Oncotarget|January 11, 2015
mTOR kinase inhibitors synergize with histone deacetylase inhibitors to kill B-cell acute lymphoblastic leukemia cellsBrandon R Beagle, Duc M Nguyen, Sharmila Mallya, et al.
Pageof 11